More articles from 07.03 - Paediatric cystic fibrosis (CF)

Diagnostic testing in people with primary ciliary dyskinesia around the world: where do we stand?
L D Schreck, E S L Pedersen, I Cizeau, C Kruljac, J S Lucas, M Goutaki, C E Kuehni

European Respiratory Journal Sep 2022, 60 (suppl 66) 4476; DOI: 10.1183/13993003.congress-2022.4476
A multimodal cell atlas of the pediatric lower airway
S Shanthikumar, J Maksimovic, A Oshlack, S Ranganathan, M Neeland

European Respiratory Journal Sep 2022, 60 (suppl 66) 4411; DOI: 10.1183/13993003.congress-2022.4411
Evaluation of performance of Dutch newborn screening program for cystic fibrosis (2016-2020)
M J Bouva, K P Van Der Ploeg, R K Verschoof - Puite, V A Gulmans, J J Gille, B S Jakobs, M Heijnen, K M De Winter - De Groot

European Respiratory Journal Sep 2022, 60 (suppl 66) 3713; DOI: 10.1183/13993003.congress-2022.3713
The efficacy of inhaled hypertonic saline in children with cystic fibrosis who receive daily DNase.
M Y Gencoglu, G D Tuğcu, Ş S Akyan Soydaş, G Cinel, N Emiralioğlu, E Yalçın, N Kiper, V Şen, D Ufuk Altıntaş, H Çokuğraş, A Ayzıt Kılınç, H Yazan, G Ünal, A I Yılmaz, H T Çağlar, E Damadoğlu, I Irmak, E Demir, G Öztürk, A Bingöl, E Başaran, N Sapan, A T Aslan, P Asfuroğlu, K Harmancı, M Köse, M Hangül, A Özdemir, G Özcan, Z G Gayretli, Ö Keskin, H Yüksel, Ş Özdoğan, E Topal, G Çaltepe, D Can, P Korkmaz Ekren, M Kılıç, T Şişmanlar Eyüboğlu, S Pekcan, N Çobanoğlu, E Çakır, U Özçelik, D Doğru

European Respiratory Journal Sep 2022, 60 (suppl 66) 4008; DOI: 10.1183/13993003.congress-2022.4008
Effect of ELX/TEZ/IVA treatment on lung ventilation in children with cystic fibrosis – comprehensive assessment using spirometry, MBW, structural and functional lung MRI
C Streibel, C C Willers, O Pusterla, G Bauman, O Bieri, E Stranzinger, B Brabandt, P Latzin, E Kieninger

European Respiratory Journal Sep 2022, 60 (suppl 66) 3919; DOI: 10.1183/13993003.congress-2022.3919
Elexacaftor-tezacaftor-ivacaftor (ETI) treatment improves Lung Clearance Index (LCI) in patients with Cystic Fibrosis (CF) independently from baseline respiratory function
F Lucca, S Volpi, R Guarise, A Borruso, M Signorini, M Cipolli

European Respiratory Journal Sep 2022, 60 (suppl 66) 3888; DOI: 10.1183/13993003.congress-2022.3888
Evaluation of factors affecting bone mineral density in CF patients through CF registry of Turkey
S S Akyan Soydaş, G D Tuğcu, M Y Gençoğlu, G Cinel, N Emiralioğlu, E Yalçın, N Kiper, V Şen, D Ufuk Altıntaş, H Çokuğraş, A Ayzıt Kılınç, H Yazan, G Ünal, A I Yılmaz, H T Çağlar, E Damadoğlu, I Irmak, E Demir, G Kartal Öztürk, A Bingöl, E Başaran, N Sapan, A T Aslan, P Asfuroğlu, K Harmancı, M Köse, M Hangül, A Özdemir, G Özcan, Z G Gayretli, Ö Keskin, H Yüksel, Ş Özdoğan, E Topal, G Çaltepe, D Can, P Korkmaz Ekren, M Kılıç, T Ş Eyüboğlu, S Pekcan, N Çobanoğlu, E Çakır, U Özçelik, D Doğru

European Respiratory Journal Sep 2022, 60 (suppl 66) 4063; DOI: 10.1183/13993003.congress-2022.4063
Search for airway-derived miRNA biomarkers in pulmonary exacerbation in children with cystic fibrosis
Z Stachowiak, B Narożna, W Langwiński, I Wojsyk Banaszak,, K Jończyk Potoczna, A Bręborowicz, A Szczepankiewicz

European Respiratory Journal Sep 2022, 60 (suppl 66) 3581; DOI: 10.1183/13993003.congress-2022.3581
Assessing the utility of home spirometry for managing children with cystic fibrosis during COVID-19 pandemic
B G Babu, B Heyeer, C Mcardle, B Davies, P Nagakumar, M Desai

European Respiratory Journal Sep 2022, 60 (suppl 66) 3375; DOI: 10.1183/13993003.congress-2022.3375
Breath profiles in cystic fibrosis children treated with CFTR modulators
E Seidl, J Licht, G Slingers, R De Vries, F Ratjen, H Grasemann

European Respiratory Journal Sep 2022, 60 (suppl 66) 3235; DOI: 10.1183/13993003.congress-2022.3235

Main menu

User menu

Search

More articles from 07.03 - Paediatric cystic fibrosis (CF)

Pages

Contact us